Reply to V. Amoroso et al

James C. Yao; Maurizio Voi; Jeremie Lincy; Marianne Pavel

doi:10.1200/JCO.2017.71.3875

Reply to V. Amoroso et al

James C. Yao, Maurizio Voi, Jeremie Lincy, Marianne Pavel

GI Medical Oncology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1488-1489
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	35
Issue number	13
DOIs	https://doi.org/10.1200/JCO.2017.71.3875
State	Published - May 1 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2017.71.3875

Cite this

@article{d287e36438e8450c92743bbda9015ad9,

title = "Reply to V. Amoroso et al",

author = "Yao, {James C.} and Maurizio Voi and Jeremie Lincy and Marianne Pavel",

note = "Funding Information: Supported by Novartis Pharmaceuticals Corporation. Clinical trial information: NCT00510068",

year = "2017",

month = may,

day = "1",

doi = "10.1200/JCO.2017.71.3875",

language = "English (US)",

volume = "35",

pages = "1488--1489",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "13",

}

TY - JOUR

T1 - Reply to V. Amoroso et al

AU - Yao, James C.

AU - Voi, Maurizio

AU - Lincy, Jeremie

AU - Pavel, Marianne

N1 - Funding Information: Supported by Novartis Pharmaceuticals Corporation. Clinical trial information: NCT00510068

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85018276607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018276607&partnerID=8YFLogxK

U2 - 10.1200/JCO.2017.71.3875

DO - 10.1200/JCO.2017.71.3875

M3 - Letter

C2 - 28113028

AN - SCOPUS:85018276607

SN - 0732-183X

VL - 35

SP - 1488

EP - 1489

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 13

ER -

Reply to V. Amoroso et al

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this